STOK   $11.44  1.51% Market Closed After Close 11.43 -0.09%

Stoke Therapeutics Inc
Total Cash 281.98M
totalCashPerShare 5.356
EBITDA -112.16M
Total Debt 5.83M
quickRatio 6.344
currentRatio 6.675
Total Revenue 15.16M
debtToEquity 2.401
Revenue/Share 0.316
ROA -0.25354
ROE -0.47847998
grossProfits
freeCashflow -21.53M
operatingCashflow -79.95M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -6.0736904
profitMargins 0.0
enterpriseValue 413.53M
forwardPE -5.3643723
floatShares 31.77M
sharesOutstanding 52.94M
sharesShort 6.79M
sharesShortPriorMonth 8.71M
dateShortInterest
sharesPercentSharesOut 0.13%
heldPercentInsiders 0.05%
heldPercentInstitutions 1.13%
Short Ratio help_outline 8.63%
shortPercentOfFloat 0.19%
impliedSharesOutstanding
bookValue 3.475
Price To Book help_outline 3.81
earningsQuarterlyGrowth
netIncomeToCommon -103.57M
trailingEps -2.17%
forwardEps -2.47%
enterpriseToEbitda -3.69
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.55 4Q 2024
institutionsCount 167
lastUpdated Nov. 7, 2024, 3:01 a.m.